AB10
AB10 is described as having pathogen-inhibiting properties against C. difficile and multidrug-resistant gram-negative bacteria. The article recommends starting AB10 when antibiotics begin rather than waiting until the course ends. The prop…
1 sources - 4 claims
AB10 is described as having pathogen-inhibiting properties against C. difficile and multidrug-resistant gram-negative bacteria. The article recommends starting AB10 when antibiotics begin rather than waiting until the course ends. The proposed AB10 protocol continues the probiotic for at least the same duration after antibiotics as during antibiotic treatment. AB10 is positioned as the preferred Omnibiotic formulation after antibiotic use.